MapLight Therapeutics, Inc. (MapLight) (Nasdaq: MPLT) today announced an update to the expected timing of topline results for its ongoing Phase ...

A 2026 industry report examining THCA flower sales activity, strain demand, and self-reported buyer usage trends based on ...

Athira Pharma, Inc. (NASDAQ: ATHA), a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for diseases with high ...

From January 6 to 9, CES 2026, held in Las Vegas-brought together 4,112 leading enterprises from around the world. As a ...

As the premier global tech event kicking off the new year, CES (Consumer Electronics Show) opened grandly in Las Vegas, ...

Brookfield Asset Management Ltd. (NYSE: BAM, TSX: BAM) ("Brookfield Asset Management") today announced it has received the requisite approval for the renewal ...

As previously communicated, Berner Industrier entered into an agreement on December 17, 2025 to acquire 100 percent of the shares in Typhonix AS and has today completed the acquisition. Typhonix start ...

Led by ICONIQ, the round brings Rain's total funding to over $338M and values the company at $1.95B - up more than 17x in just 10 monthsThe new funding enables Rain to scale its global, compliant ...

Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for ...

Colabor Group Inc. (TSX: GCL) ("Colabor" or the "Company"), announces that the Superior Court of Quebec (Commercial Division) (the ...

Confirmed wild-type CFTR delivery and expression in conducting airway cells of patients with class I mutations KB407 transduction confirmed in all six patients with successful bronchoscopies irrespect ...

Cellectis (the "Company") (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop ...